Chloroquine ototoxicity


Chloroquine (CQ), a 4-aminoquinoline drug, has been largely used for the treatment of rheumatoid arthritis and other connective tissue diseases. Besides the well-known retinal toxicity, its use has been suspected of be associated to ototoxicity. Some reports have described mainly sensorineural hearing loss, tinnitus, sense of imbalance, and cochleovestibular manifestations. Differently from what occurs in retinopathy, in which there is a predominance of CQ toxicity, there are reports of alterations in hearing related to either CQ or hydroxychloroquine. Brain-evoked response audiometry seems to be the most sensitive test in detecting early manifestations of cochlear injury caused by CQ when still in a reversible stage. The reversibility of CQ ototoxicity has been debatable, but there is suggestion that such complication can be corrected if the medication is stopped and appropriate therapy, with steroids and plasma expanders, is instituted.

This is a preview of subscription content, access via your institution.


  1. 1.

    Page F (1951) Treatment of lupus erythematosus with mepacrine. Lancet 2:755–758

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Johansen PB, Gran JT (1998) Otoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol 16:472–474

    PubMed  CAS  Google Scholar 

  3. 3.

    Hart EW, Naunton RE (1964) The ototoxicity of chloroquine phosphate. Arch Otolaryngol 80:407–412

    PubMed  CAS  Google Scholar 

  4. 4.

    Rynes NI (1997) Antimalarial drugs in the treatment of rheumatological disease. Br J Rheumatol 36:799–805

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Scherbel AL, Harrison JW, Atojian M (1958) Further observations on use of a 4-amino-quinolone compounds in patients with rheumatoid arthritis or related diseases. Clinical Quarterly 25:95–111

    CAS  Google Scholar 

  6. 6.

    Hadi U, Nuwayhtd N, Hasbini AS (1996) Chloroquine ototoxicity: an idiosyncratic phenomenon. Otolaryngol Head Neck Surg 114:491–493

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Matz GJ, Naunton RF (1968) Ototoxicity of chloroquine. Arch Otolaryngol 88:370–372

    PubMed  CAS  Google Scholar 

  8. 8.

    Seckin U, Ozoran K, Ikinciogullari A et al (2000) Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int 19(5):203–204

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Mukherjee DK, Mukherjee K (1978) Ototoxicity of commonly used pharmaceutical preparations. Niger Med J 3:20–24

    Google Scholar 

  10. 10.

    Mukherjee DK (1979) Chloroquine ototoxicity—a reversible phenomenon? J Laryngol Otol 93:809–815

    PubMed  CAS  Google Scholar 

  11. 11.

    Roverano S, Cassano G, Paira S et al (2006) Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus. J Clin Rheumatol 12:217–220

    PubMed  Article  Google Scholar 

  12. 12.

    Bernard P (1985) Alterations of auditory evoked potentials during the course of chloroquine treatment. Acta Oto-laryngol 99:387–392

    CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Mittermayer Santiago.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bortoli, R., Santiago, M. Chloroquine ototoxicity. Clin Rheumatol 26, 1809–1810 (2007).

Download citation


  • Chloroquine
  • Ototoxicity